 SHANGHAI, July 27, 2021 PRNewswire-- Zhongchao Inc. NASDAQ: ZCMD Zhongchao or the Company, a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform Platform built and operated by the Company. There are approximately 2.5 million breast cancer patients in China, with more than 400,000 new cases each year. 